Diving into Grifols legacy, we're proud to share a remarkable chapter from our history that continues to inspire us. The pioneering work of Dr. Josep Antoni Grífols i Lucas in 1951 on plasmapheresis marked a turning point in medical science and the plasma industry. His dedication and innovative approach led to a landmark study involving over 350 donors, proving the safety ofthe procedure on donors. The findings presented at an international congress of transfusion medicine and published in the British Medical Journal the next year have been instrumental. It enabled the collection of plasma on a larger scale, offering the scientific community a technique that continues to be the most widespread method for obtaining plasma for the industrial fractionation process to the present day. His legacy continues to inspire us at Grifols as we forge ahead, innovating for patients. Learn more about our history of innovation 👉 http://spr.ly/6048c1YU0
Gonde Mavolo
2mo
Good company to work for
Frank Peropat
2mo
Impressive growth!
Entrepreneur and Healthcare Campaigner
2moCongratulations to Grifols for their long standing record in this field, and for highlighting the assured donor safety aspect. Donor safety is course hugely important, worldwide, and the message both needs and deserves wider exposure, education and publicity. While more than 80% of the World's needy patients are being deprived of adequate supplies of plasma-derived medicines, it is deeply disappointing and, frankly, disgraceful that the availability of human plasma is so low, globally. There remain countries where pheresis is largely ignored or even actually prohibited. There remain those who still argue - utterly mistakenly - that compensated plasma collection by pheresis is somehow damaging, dangerous or unethical. While these primitive superstitions remain so widespread, very little progress will be possible. Patients will continue to suffer and die unnecessarily, in large numbers. Now therefore is a great time to remind ourselves of Dr Grifols' pioneering work in the 40s and 50s and re-publicise the hugely important matter of donor safety assurance. To help the deeply underserved patient populations in Low and Middle Income Countries, we should all be shouting the safe pheresis message from the rooftops!! Please repost.